Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mt Sinai J Med. 2001 Sep-Oct;68(4-5):268-78.

Current therapy of pemphigus vulgaris.

Author information

  • 1Department of Dermatology, Box 1047, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.

Abstract

Pemphigus vulgaris (PV) is a potentially fatal autoimmune blistering disease of the skin and mucous membranes, characterized by flaccid bullae that rupture and leave erosions. Its treatment is challenging. Although the use of systemic corticosteroids remains the cornerstone of effective therapeutic regimens for PV, their prolonged administration may lead to serious side effects. It is therefore necessary, for many patients, to add immunosuppressive agents or use immunomodulatory procedures to achieve remission. This paper will summarize the treatments available for PV, while focusing on the most recently available therapeutic options.

PMID:
11514914
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk